Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base

CHAPEL HILL, N.C., Dec. 12, 2011 /PRNewswire/ -- Public Relations tactics and tools are broad-reaching, affecting millions of consumers when successful. This makes Public Relations a highly leveraged marketing investment, requiring relatively low investment to reach large audiences. More specifically, Public Relations tools can be easily utilized to benefit all phases of the product lifecycle, especially at launch and brand-building years.

However, field research suggests few companies maximize the full potential of PR campaigns throughout the entire product lifecycle – from preparing and launching to growing and extending a brand, according to Best Practices, LLC study, "Using Public Relations to Launch, Grow and Extend Your Brands."

While Public Relations have long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach consumers has never been greater. This research will help companies take advantage of the many recommendations and actions to better align PR activities and tactics during the different stages of a product's lifecycle.

Public Relations can also help build a bridge from between a first-generation success to a future blockbuster. Field findings revealed that successor product teams generally should commence Public Relations two years prior to the new product's global launch.

Study topics include:

• Public relations tools and tactics that are most effective at different lifecycle stages
• The most effective public relations tools and calls-to-action
• Successful web site resources for consumers
• Ideal budget ratios and performance measurements
• Lessons learned and best practices

The full 108-page report contains over 600 benchmark metrics and more than 35 best practices, delivering insights into the most effective Public Relations channels, tactics and calls-to-action for reaching consumers of pharmaceutical products provided by 18 top biopharmaceutical companies.

Specifically, this research document identifies which Public Relations activities most effectively educate and inform consumers at different points in a product's lifecycle. In addition, this study provides leaders with insights into performance measurements for PR campaigns and what web-based resources best engage patients.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http:/www.best-in-class.com/rr1085.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.

SOURCE Best Practices, LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED